Navigation Links
Leading Cord Blood Experts Clarify Their Support of CORD:USE Family Cord Blood Bank
Date:6/17/2010

ORLANDO, Fla., June 17 /PRNewswire/ -- CORD:USE Cord Blood Bank, a public cord blood banking facility, and its Team of cord blood pioneers and leaders announced last month their plans to open a family cord blood bank to offer its high quality services to new parents who elect to privately bank their baby's cord blood.  The Team of experts in cord blood biology, banking and transplantation includes Drs. Hal Broxmeyer, Joanne Kurtzberg, John Wagner, Eliane Gluckman and Alan Levine.  

In response to the announcement last month, other cord blood banks have referred to our Leadership Team's support of family banking.  As a result, CORD:USE's Team of experts would like to clarify their specific support of CORD:USE's family banking program, and to make it clear that their support of family cord blood banking is not a universal endorsement of all family banking enterprises or of unproven therapeutic uses of autologous cord blood cells.  These experts have reviewed and/or helped develop the banking, educational and marketing practices at CORD:USE.  They strongly believe that: CORD:USE utilizes the highest quality technologies and banking practices; is a leading and experienced public bank, helping to build, with other banks, the National Cord Blood Inventory in the U.S., and is completely committed to providing expectant parents with medically and scientifically accurate information about present clinically proven and experimental cord blood uses, so that they can choose the option that is right for them.  

"We are very honored to have many of the world's leaders in this field on our team and supporting our public and family cord blood banks," said Edward S. Guindi M.D., President and CEO of CORD:USE.


'/>"/>
SOURCE CORD:USE Cord Blood Bank
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
2. Elekta Contract Provides Sisters of Mercy Health System Access to Leading Radiation Therapy Solutions
3. United BioSource Acquires Interest in Leading Adaptive Design Technology Service Provider
4. Panel to Discuss the Far-Ranging Effects and Consequences of Heart Disease, Which is the Leading Killer in Both Men and Women in the United States
5. FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia
6. Cooler Solutions and Leading Research Hospital to Design Revolutionary Osteoporosis Diagnosis Device
7. K-State Research Leading to Software to Help Nations Cattle Producers Identify Biosecurity Risks, Evaluate Impact of Cow-Calf Diseases Online
8. Leading Biotechnology Company Grows with StayinFront CRM
9. Leading Pharmaceutical Communication Executives Gather for the 1st Annual Pharmaceutical Public Relations Symposium
10. Agendia Acquires Rights to the Discovery of a Major Drug Resistance Mechanism in Breast Cancer Potentially Leading to a Herceptin(R) Sensitivity Test
11. 2007 Massachusetts Biotechnology Council MASS Opportunities Investment Conference Showcases Leading Growth Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... ... for their exceptionally efficient human mesenchymal stem/stromal cell (hMSC) expansion medium. ... media products engineered to radically streamline culture processes, minimize processing time, significantly ...
(Date:12/8/2016)... , Dec. 8, 2016  Soligenix, Inc. ... biopharmaceutical company focused on developing and commercializing products ... unmet medical need, announced today the long-term follow-up ... SGX942 (dusquetide), a first-in-class Innate Defense Regulator (IDR), ... head and neck cancer patients undergoing chemoradiation therapy ...
(Date:12/8/2016)... 2016 Savannah River Remediation LLC group ... NewTechBio,s NT-MAX Lake & Pond Sludge and ... in conjunction with Hexa Armor/ Rhombo cover manufactured ... Pollutant Discharge Elimination System requirements. The ... history of elevated pH levels, above 8.5, especially ...
(Date:12/8/2016)...   Biocept, Inc . (NASDAQ: ... actionable liquid biopsy tests to improve the management ... its Target Selectorâ„¢ Circulating Tumor Cell platform demonstrated ... of actionable biomarkers in patients with metastatic breast ... Cannon Research Institute (SCRI), the research arm of ...
Breaking Biology Technology:
(Date:12/6/2016)... 2016 Valencell , the leading innovator ... seen a third consecutive year of triple digit growth ... 2016 with a 360 percent increase in companies who ... was driven by sales of its wrist and ear ... its technology for hearables for fitness and healthcare applications. ...
(Date:12/2/2016)... Texas , Dec. 1, 2016   ... today announced BioLock , an electrocardiogram (ECG) ... health monitoring, a key IoT asset. The smart ... into a vehicle,s steering wheel and mobile devices ... simple touch. As vehicle technology advances, ...
(Date:11/29/2016)... Nov. 29, 2016   Neurotechnology , ... object recognition technologies, today released FingerCell 3.0, ... recognition solutions that run on low-power, low-memory ... using less than 128KB of memory, enabling ... that have limited on-board resources, such as: ...
Breaking Biology News(10 mins):